Siemens AG is currently reviewing its majority stake in the medical technology subsidiary of Siemens Healthineers.
The mentioned statement was made by Siemens’ chief financial officer Ralf Thomas during a conversation with media representatives. According to him, the synergy with the manufacturer of machines for magnetic resonance imaging and laboratory systems is not large enough to justify a capital commitment of 45 billion euros ($49.91 billion). The mentioned amount is the equivalent of the value of 75% of Siemens’ equity stake.
According to Ralf Thomas, the process of evaluating Siemens AG’s economic opportunities in the healthcare sector is currently underway. After that, a derive will be made about how effective Healthineers is as an investment. Then a general conclusion will be drawn. Ralf Thomas also stated that the relevant results will be presented on capital markets day at the end of 2025.
Siemens AG spun off the Erlangen, Germany-based subsidiary in 2018 and floated it on the stock exchange. It is worth noting that the company has stated in the past that it will keep a majority stake in Siemens Healthineers. At the same time, in October, Ralf Thomas announced the prospect of selling 5% of shares to finance the takeover of Altair, a software development company based in the United States. Also, according to Mr. Thomas, he remains committed to the Mobility train unit. It is worth noting that investors have repeatedly called for this unit to be spun off.
Ralf Thomas stated that the business is in good hands with Siemens AG and he sees no need to part with it at the moment.
It is worth noting that in this case there is a remarkable case. For the first time, Siemens AG questioned its commitment to medical technology. Against the background of the relevant news, the value of Siemens Healthineers shares fell by about 3%. Then this indicator stabilized slightly, amounting to 51 euros.
Last month, Siemens AG announced that it expects moderate macroeconomic growth in fiscal year 2025. In the relevant context, the company drew attention to the impact of such a factor as the continuing uncertainty in the space of geopolitical relations. It is worth noting separately that there is also a consistent increase in tension in the mentioned space. Moreover, Siemens AG mentioned trade conflicts in the context of the specified uncertainty. Many experts currently assess the risk of rising trade tensions as a realistic prospect. To a large extent, Donald Trump’s victory in the United States presidential election last month contributed to the corresponding perception of this potential scenario. During his election campaign, Mr. Trump repeatedly pledged to raise tariffs on imported goods. After winning the election, he confirmed his commitment to the relevant intention.
As part of its forecast for 2025, Siemens AG also mentioned the continuing challenges in the manufacturing sector. In this case, factors such as overcapacity and weak consumer demand are implied. At the same time, the infrastructure markets, especially in the areas of electrification and mobility, remain strong.
As we have reported earlier, Siemens to Invest €2 Billion to Boost High-Tech Plants.
